JP2017512842A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512842A5
JP2017512842A5 JP2017504259A JP2017504259A JP2017512842A5 JP 2017512842 A5 JP2017512842 A5 JP 2017512842A5 JP 2017504259 A JP2017504259 A JP 2017504259A JP 2017504259 A JP2017504259 A JP 2017504259A JP 2017512842 A5 JP2017512842 A5 JP 2017512842A5
Authority
JP
Japan
Prior art keywords
stem cells
ang1
cells
vegf
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017504259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512842A (ja
JP6882161B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/057521 external-priority patent/WO2015155187A1/en
Publication of JP2017512842A publication Critical patent/JP2017512842A/ja
Publication of JP2017512842A5 publication Critical patent/JP2017512842A5/ja
Application granted granted Critical
Publication of JP6882161B2 publication Critical patent/JP6882161B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017504259A 2014-04-07 2015-04-07 改善された幹細胞組成物 Active JP6882161B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014901247A AU2014901247A0 (en) 2014-04-07 Improved stem cell composition
AU2014901247 2014-04-07
PCT/EP2015/057521 WO2015155187A1 (en) 2014-04-07 2015-04-07 Improved stem cell composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021024189A Division JP7196216B2 (ja) 2014-04-07 2021-02-18 改善された幹細胞組成物

Publications (3)

Publication Number Publication Date
JP2017512842A JP2017512842A (ja) 2017-05-25
JP2017512842A5 true JP2017512842A5 (cg-RX-API-DMAC10.html) 2018-05-31
JP6882161B2 JP6882161B2 (ja) 2021-06-02

Family

ID=53724311

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017504259A Active JP6882161B2 (ja) 2014-04-07 2015-04-07 改善された幹細胞組成物
JP2021024189A Active JP7196216B2 (ja) 2014-04-07 2021-02-18 改善された幹細胞組成物
JP2022198585A Active JP7571109B2 (ja) 2014-04-07 2022-12-13 改善された幹細胞組成物
JP2024176634A Pending JP2024177516A (ja) 2014-04-07 2024-10-08 改善された幹細胞組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021024189A Active JP7196216B2 (ja) 2014-04-07 2021-02-18 改善された幹細胞組成物
JP2022198585A Active JP7571109B2 (ja) 2014-04-07 2022-12-13 改善された幹細胞組成物
JP2024176634A Pending JP2024177516A (ja) 2014-04-07 2024-10-08 改善された幹細胞組成物

Country Status (9)

Country Link
US (4) US10400218B2 (cg-RX-API-DMAC10.html)
EP (2) EP3129468B1 (cg-RX-API-DMAC10.html)
JP (4) JP6882161B2 (cg-RX-API-DMAC10.html)
KR (2) KR102577698B1 (cg-RX-API-DMAC10.html)
CN (2) CN113337462A (cg-RX-API-DMAC10.html)
AU (4) AU2015243575B2 (cg-RX-API-DMAC10.html)
CA (1) CA2944262C (cg-RX-API-DMAC10.html)
SG (2) SG10202000644TA (cg-RX-API-DMAC10.html)
WO (1) WO2015155187A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
KR102577698B1 (ko) 2014-04-07 2023-09-12 메조블라스트 인터내셔널 에스에이알엘 개선된 줄기 세포 조성물
WO2015189063A1 (en) * 2014-06-10 2015-12-17 Mesoblast International Sàrl Treatment of immune disorders
JP6231709B1 (ja) * 2016-05-31 2017-11-15 シスメックス株式会社 蛍光画像分析装置および分析方法
EP3619294A1 (en) * 2017-05-04 2020-03-11 Mesoblast International Sàrl Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
CN113677790B (zh) * 2019-03-26 2024-05-24 普罗米瑟拉疗法公司 用于治疗慢加急性肝衰竭的成体肝祖细胞
US11697799B2 (en) 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
WO2021176001A1 (en) 2020-03-05 2021-09-10 Mesoblast International Sàrl Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
EP4181675A4 (en) 2020-07-18 2024-04-24 Ossium Health, Inc. PERMEATION OF WHOLE VERTEBRATE BODIES WITH A CRYOPRETECTIVE AGENT USING VACUUM-ASSISTED DIFFUSION
EP4229183A4 (en) 2020-10-14 2024-12-11 Ossium Health, Inc. Compositions and methods for extraction of mesenchymal stem cells
EP4228406A4 (en) 2020-10-14 2024-11-13 Ossium Health, Inc. SYSTEMS AND METHODS FOR BONE MARROW EXTRACTION AND CRYOPRESERVATION
EP4262831A4 (en) 2020-12-18 2025-01-01 Ossium Health, Inc. CELLULAR THERAPY PROCESSES
WO2022173737A1 (en) 2021-02-09 2022-08-18 Millennium Pharmaceuticals, Inc. Methods and compositions for freezing and thawing mammalian cells
JP2025538783A (ja) * 2022-12-09 2025-11-28 メゾブラスト・インターナショナル・エスアーエールエル 事前承認された組成物及び細胞培養方法
AU2023389700A1 (en) * 2022-12-09 2025-07-10 Mesoblast International Sarl Method of treating heart failure in subjects with persistent inflammation
WO2024121821A1 (en) * 2022-12-09 2024-06-13 Mesoblast International Sarl Conditioned media and use of the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
JP2001508302A (ja) 1997-01-10 2001-06-26 ライフ テクノロジーズ,インコーポレイテッド 胚性幹細胞血清置換
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AU2005209688A1 (en) * 1999-07-07 2005-10-06 Angioblast Systems, Inc. Mesenchymal precursor cell
JP2003052360A (ja) * 2001-08-20 2003-02-25 Japan Science & Technology Corp 基底膜細胞外基質を用いた間葉系幹細胞の培養方法
KR20050111593A (ko) * 2003-02-19 2005-11-25 가부시키가이샤 디나벡크 겐큐쇼 허혈질환의 치료방법
CN101103101B (zh) * 2004-09-24 2012-10-10 成血管细胞系统公司 增强间充质前体细胞(mpc)的增生和/或存活的方法
US8367405B2 (en) 2005-04-12 2013-02-05 Mesoblast, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
WO2007122233A1 (en) * 2006-04-25 2007-11-01 Vrije Universiteit Brussel Preparation of mesenchymal progenitor cells, particularly osteogenic progenitor cells
CN101407790B (zh) * 2008-10-30 2010-09-29 浙江大学 一种增强人骨髓间充质干细胞旁分泌能力的处理方法
EP2258413A1 (en) * 2009-06-04 2010-12-08 Université Catholique de Louvain Multi-dimensional biomaterial and method for producing the same.
JP5888670B2 (ja) * 2010-11-18 2016-03-22 国立大学法人東京工業大学 骨芽細胞分化誘導用培養基材、骨芽細胞分化誘導方法、及び骨芽細胞製造方法
CN102899293A (zh) * 2012-11-01 2013-01-30 上海市肺科医院 促血管生成素1基因修饰的间充质干细胞、及其构建方法与应用
KR102019540B1 (ko) * 2013-12-18 2019-09-06 아이디에이씨 홀딩스, 인크. 전이중 무선 시스템에서의 간섭 관리 방법, 장치 및 시스템
KR102577698B1 (ko) * 2014-04-07 2023-09-12 메조블라스트 인터내셔널 에스에이알엘 개선된 줄기 세포 조성물

Similar Documents

Publication Publication Date Title
Liao et al. Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b
Wang et al. STAT3 mediates bone marrow mesenchymal stem cell VEGF production
Dissanayaka et al. In vitro analysis of scaffold-free prevascularized microtissue spheroids containing human dental pulp cells and endothelial cells
Gamblin et al. Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages
Liang et al. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury
Sun et al. Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy
Kawashima et al. Properties of dental pulp–derived mesenchymal stem cells and the effects of culture conditions
JP2022078044A (ja) コロニー形成培地及びその使用
Dimitrova-Nakov et al. Pulp stem cells: implication in reparative dentin formation
JP6883904B2 (ja) 線維芽細胞の製造方法及びg−csf陽性線維芽細胞集団
KR20160145066A (ko) 개선된 줄기 세포 조성물
Noseda et al. The quest for the adult cardiac stem cell
Zhang et al. Cotransplantation of human umbilical cord mesenchymal stem cells and endothelial cells for angiogenesis and pulp regeneration in vivo
Liu et al. Human gingival fibroblasts induced and differentiated into vascular endothelial‐like cells
Basabrain et al. Interactions of neuronally induced stem cells from apical papilla spheres, stems cells from apical papilla, and human umbilical vascular endothelial cells on Vasculogenesis and neurogenesis
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Sun et al. MiR-98-5p regulates myocardial differentiation of mesenchymal stem cells by targeting TBX5.
CN101407790B (zh) 一种增强人骨髓间充质干细胞旁分泌能力的处理方法
JP6173157B2 (ja) Il−17産生抑制組成物
Sun et al. Autologous oxygen release nano bionic scaffold composite miR-106a induced BMSCs enhances osteoblast conversion and promotes bone repair through regulating BMP-2.
KR102926744B1 (ko) 조직 내재성 uPAR+ 줄기세포 및 이의 용도
CN103205394A (zh) 培养基及其应用
Fariha et al. Endogenous and induced angiogenic characteristics of human chorion‐derived stem cells
KR102476348B1 (ko) 조직 내재성 uPAR+/Nestin+ 줄기세포 분리 배양 방법 및 이의 용도
Abraham et al. Neural differentiation and support of neuroregeneration of non-neural adult stem cells